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HEPATIC LIPID IN GOLDTHIOGLUCOSE-OBESE MICEt
For several years we in this laboratory have been interested in the effects of
obesity on the liver. Accumulations of fat have been observed in the livers
of rats with insulin-induced polyphagia' and also in rats with hypothalamic
polyphagia and obesity.' In both cases, the fat was present periportally
rather than centrolobularly.
Elevation of hepatic lipid content has been described by several observers
in mice which became obese after receiving goldthioglucose. Brecher and
Waxler,8 in reporting the initial observations of goldthioglucose-induced
obesity, noted that abnormal amounts of stainable lipid were present centro-
lobularly in the livers of the obese mice. Subsequently the accumulation of
fat in livers of obese mice has been confirmed histologically and biochem-
ically in several laboratories,"9"10 but except for the initial report by Brecher
and Waxler,I we have found no description of the lobular distribution, nor
published photomicrographs. The study reported here was undertaken to
investigate further the effects of goldthioglucose-induced obesity on hepatic
lipid and to determine whether the fatty change could be attributed to a toxic
effect of the goldthioglucose rather than to polyphagia and obesity.
MATERIALS AND METHODS
Two experiments were performed using male, CFW, albino mice. They were kept
in individual cages at 24-26° C. and were given a commercial stock diett and water
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ad libitum. Goldthioglucose was injected intraperitoneally in a concentration of 100
mg. per ml. of sesame oil.* At the termination of each experiment, the mice were
weighed and were killed by decapitation. Blocks of liver were fixed in formalin con-
taining 100 gm. each of calcium chloride and cobaltous nitrate per liter. Sections were
cut with a freezing microtome and were stained for fat with oil red 0. Blocks of
livers of selected animals from Experiment II were fixed for one hour in Dalton's
chrome-osmic acid fixative, washed, dehydrated in alcohol, and embedded in a solution
of 1 part butyl methacrylate in 7 parts of methyl methacrylate with benzoyl peroxide
added as the polymerizing agent. Polymerization was carried out at 600 C. Small
central veins were located by phase microscopy, and each block was trimmed to leave
only the tissue including and immediately around a central vein. After thin sections
were cut using a Porter-Blum microtome, the centrolobular localization was confirmed
again by phase microscopy. The thin sections were photographed with a RCA Model
EMU-2B electron microscope. Blocks from the same livers were also fixed in Carnoy's
solution and paraffin sections were stained for glycogen by the PAS technique using
duplicate sections digested by diastase as controls.
Experiment I utilized 200 mice. One hundred sixty received one or more injections of
goldthioglucose. For the 35 injected mice that survived until the termination of the
experiment, the initial doses ranged from 0.43 to 1.1 mg. of goldthioglucose per
gm. body weight. Animals that survived for one month without abnormal weight-gain
were given a second dose of goldthioglucose, 20 mg., intraperitoneally. Five mice
received a third dose, 20 mg., after one more month. Thirty-eight mice were not given
goldthioglucose and served as controls. Nineteen of them survived to the termination
of the experiment. The mice initially were divided into two dietary groups, with each
group made up of one-half of the injected and one-half of the uninjected mice. One
group received a diet marginal in lipotropic adequacy for albino rats but otherwise
sufficient in all essential dietary constituents.2' The second group received a similar
diet supplemented with choline chloride to a level of 0.5 per cent by weight. During
the last four months, all mice received the commercial diet. At autopsy the mice
showed no apparent differences attributable to the initial differences in diets.
Experiment II, in which 84 mice were used, was performed to extend the observations
of Experiment I. Thirty-seven mice received a single injection of goldthioglucose when
approximately three months old and weighing 21-30 gm. Ten received 1 mg. per gm.,
10 received 1.5 mg. per gm., and 17 received 2.0 mg. per gm. Fourteen mice of similar
carbonate, and 1 per cent salt. Average analysis (per cent): protein 21.93, fat 3.15,
fiber 4.86, carbohydrates 56.23, nitrogen-free extract 52.29, and ash 7.78. Mineral
composition (per cent): silicon dioxide 0.59, chlorine 0.70, sodium 0.41, potassium
0.72, calcium 1.68, phosphorus 0.80, sulphur 0.24, magnesium 0.33, manganese 0.0084,
iron 0.019, zinc 0.002, copper 0.0012, boron 0.00137, cobalt 0.000035, iodine 0.0012, and
fluorine 0.0019. Vitamin content per 100 gm.: vitamin A 610-680 U.S.P. units, thia-
mine 228-465 /sg, riboflavin 436-650 ug., pyridoxine 209-275 mcg., pantothenic acid
1000-1594 ug., choline equivalent 480-492 mg., inositol (free) 61 mg., vitamin D 148
U.S.P. units, vitamin E 1.2 international units, PABA 78 /'g., niacin 6.60 mg., vita-
min C 3.6 mg., carotene 0.42-0.45 mg., and choline 132 mg. Representative amino acid
content (per cent): lysine 1.15, methionine 0.40, cystine 0.29, tryptophane 0.27, argi-
nine 1.39, histidine 0.53, isoleucine 1.20, leucine 1.74, phenylaline 1.03, threonine 0.87,
valine 1.14, and tyrosine 0.72.
* The goldthioglucose was generously supplied by Preston H. Perlman, Ph.D.,
Director, Biochemical Research, Schering Corporation, Bloomfield, New Jersey.
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age and weight were uninjected controls. Surviving animals were autopsied after
nine weeks.
To investigate possible toxic effects of goldthioglucose or its sesame oil vehicle on
the liver, two more groups of mice were used. They were similar to the others with
respect to age and weight. Each member of a group of 14 received V3 mg. goldthio-
glucose per gm. body weight intraperitoneally weekly until the experiment was
terminated after nine weeks. To explore the acute effects of goldthioglucose, each
member of a group of 19 mice was killed or allowed to die spontaneously within four
days after intraperitoneal injection of goldthioglucose. Ten received 1 mg. per gm. of
body weight, and 9 received 2 mg. per gm.
The heaviest uninjected mouse in Experiment I weighed 42 gm., and all mice that
weighed 45 gm. or more were arbitrarily designated obese. The short duration of
Experiment II did not permit maximum differences in body weight between obese
and nonobese animals to develop; consequently obesity was defined in terms of weight-
gain (10 gm. or more) rather than in terms of final body weight. No uninjected
control gained more than 7 gm.
Concentrations of stainable hepatic lipid were estimated for periportal and centro-
lobular locations by a method previously reported from this laboratory.' The grading
system was as follows: Grade 0-no fat recognizable at 100 x magnification. Grade 1
fat present, but in no more than 50 per cent of cells. Grade 2-fat present in more than
50 per cent but in less than 85 per cent of cells. Grade 3-fat present in more than
85 per cent of cells, but no more than 15 per cent of cells heavily laden with fat (i.e.,
50 per cent or more of cytoplasm composed of fat). Grade 4-more than 15 per cent
but not more than 50 per cent of cells heavily laden with fat. Grade 5-intermediate
between Grade 4 and Grade 6. Grade 6: more than 85 per cent of parenchymal
cytoplasm in area under consideration filled with fat. Actual counts of cells were not
made, but this method of ranking provided a reliable basis for semiquantitative
estimation of fat-content. Livers were examined by one of us (JSM) without
knowledge of the identities of the animals from which they came.
The numerical data were analyzed by means of the t test adapted to the analysis of
small groups.'
RESULTS
Inboth experiments, obesity as determined by body weight was associated
with centrolobular deposition of stainable lipid (Fig. 1 and Tables 1 and 2).
Differences in the amounts of centrolobular lipid between goldthioglucose-
obese mice and mice that received goldthioglucose but did not become obese
are highly significant at the P<O.OO1 level of confidence in both Experi-
ments I and II. Differences between the obese mice and the uninjected
controls are also highly significant (P<O.OO1). The centrolobular accumu-
lation of fat associated with obesity was generally proportional to the degree
of obesity with a few exceptions. Significant periportal accumulation of
stainable lipid did not occur in any obese mouse. The largest amount of
periportal lipid occurring in an obese mouse was Grade 2, and in that mouse
310
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the centrolobular grade was 4. In none of the obese mice did the degree of
periportal fatty change equal that in the center of the lobule.
Obesity was limited to mice that received injections of goldthioglucose
larger than 0.6 mg. per gm. of body weight. None of the mice of Experi-
ment II that were given nine weekly injections of 0.33 mg. of goldthioglucose
per gm. of body weight became obese.
The centrolobular lipid in the livers of obese mice occurred as small
droplets within the cytoplasm of parenchymal cells. The droplets usually
remained small and failed to coalesce even in very fatty cells (Figs. 5 and 6).
By light microscopy, the fat had a finely bubbly appearance instead of the
homogeneous appearance characteristic of large globules. Fatty cysts were
extremely rare. Fat-laden hepatic parenchymal cells of obese mice main-
tained their polygonal outlines, and their nuclei were usually centrally
located. The fat-laden cells were enlarged, but not distorted by their
content of lipid.
By electron microscopy thin septa could be seen separating the small
globules of fat (Fig. 9). These septa consisted of cytoplasm in which
ergastoplasmic membranes or other organelles could not be identified. The
fat was not consistently related to mitochondria. Most of it had been lost
during the preparation of the tissue, but fat-containing vacuoles usually
retained small amounts of osmophilic material.
Mitochondria of the centrolobular parenchymal cells of obese, fatty livers
were in no way different from those of nonobese, nonfatty livers of injected
or noninjected animals (Figs. 11 and 12). Not only were changes in mito-
chondria not demonstrable among different animals, but also when mito-
chondria of fatty and nonfatty cells in the same animal were compared no
differences were found.
The amount and distribution of stainable lipid in livers of the mice that
received multiple doses of goldthioglucose to a total of 3 mg. per gm. of
body weight and in the livers of nonobese mice that received single injec-
tions were similar. Small amounts of centrolobular lipid were observed in
most livers, and the fat was contained in small vacuoles in parenchymal
cytoplasm (Figs. 2 and 3).
In Experiment II, the amount of centrolobular lipid in livers of nonobese,
injected mice and multiple-injected mice was significantly in excess of the
amount in livers of the noninjected mice (P<0.01 for both comparisons).
A few of the noninjected mice showed very small amounts of hepatic lipid,
but most were completely devoid of it (Fig. 4). In Experiment I, livers of
12 of the nonobese, injected mice contained no stainable lipid, and in Experi-
ment II, three of the nonobese, injected mice, including two that received
312
Volume 33, February 1961Hepatic lipid and goldthioglucose obesity I MEYER, IMAI, SCOTT
multiple injections, showed no stainable hepatic lipid. The difference in
amount of centrolobular lipid between the two nonobese groups of Experi-
ment I is not significant.
In the experiment designed to test the acute effects of goldthioglucose,
the mice that were given 1.0 mg. per gm. of body weight all survived until
they were killed two or four days after injection. No stainable lipid was
observed in their livers. Nine of the mice had lost weight during the period
after injection, and one showed no change in weight.
Five of the mice receiving 2.0 mg. of goldthioglucose per gm. body weight
died within 24 hours after injection, and 2 more were killed at that time
because they were moribund. The livers of these animals contained variable
amounts of stainable lipid, but it was always located periportally rather than
centrolobularly. The 2 remaining mice were killed four days after injection,
and neither showed any stainable hepatic lipid. Thus of the 19 mice observed
for acute effects of large doses of goldthioglucose on the liver, only those
that died or were killed when moribund showed any fatty change, and the
lipid that did occur was chiefly periportal.
Yellow pigment was present consistently in Kupffer cells of the mice that
had received goldthioglucose (Fig. 8). It was not seen in uninjected ani-
mals. In general, the amount of pigment was proportional to the dose of
goldthioglucose. The greatest quantities were found in livers of the mice
that had received 3 mg. per gm. body weight. The pigment gave a positive
reaction when stained by the stannous chloride method for gold" (Fig. 7).
It did not contain stainable iron. It was insoluble in alcohol and xylol,
PAS-negative, and oil red 0 failed to stain it in sections cut from tissue
embedded in paraffin. These observations indicate that the pigment contains
gold, and that it is free of ceroid and hemosiderin. Trace amounts of ceroid
were found in Kiipffer cells in all experimental groups and in controls
without significant variation among groups.
The gold-containing pigment was distributed evenly throughout the
hepatic lobule in contrast to the pericentral localization of fat. In electron
micrographs it was extremely dense, and some deposits had crystalloid
patterns (Fig. 10).
The PAS-stained sections showed no significant variations of hepatic
glycogen content or its lobular distribution among the different groups in
Experiment II. Most livers contained abundant glycogen. Livers of the
mice killed acutely were not stained for glycogen.
In both Experiment I and Experiment II, the livers of obese animals were
heavier than the livers of nonobese animals. The differences are significant
at the P<0.001 level in Experiment I.
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In Experiment II, the difference between the mean weights of the livers of
the obese and the once-injected, nonobese mice are significant at the
P<O.OO1 level, and the differences between the obese and the uninjected,
nonobese are significant at the P<O.O1 level. The differences between the
hepatic weights of the obese mice and the multiple injected, nonobese mice
are also significant at the P<O.O1 level. In neither experiment did the
weights of the livers of the nonobese groups differ significantly.
DISCUSSION
The observation originally made by Brecher and Waxler that abnormal
amounts of lipid accumulate centrolobularly in the livers of goldthioglucose-
obese mice is confirmed. The data suggest that obesity, rather than a toxic
effect of goldthioglucose or its sesame oil vehicle, is responsible for most of
the fatty change.
Although increases in centrolobular stainable lipid occurred in some
nonobese, injected mice relative to the noninjected controls, the degree of
fatty change was not proportional to the dose of goldthioglucose given
either as single or multiple injections. Mice killed or dying acutely follow-
ing injection of goldthioglucose did not show increased centrolobular stain-
able lipid. These observations suggest that the minimal centrolobular fatty
changes in livers of nonobese, injected mice may not have been due to an
hepatotoxic effect of the goldthioglucose. It is possible that the arbitrary
criteria based on body weight, or weight gain, failed to detect all of the obese
mice with the result that a few animals in the nonobese, injected groups
might actually have been slightly polyphagic and obese. Further evidence
against a postulate that the hepatic fatty change might represent a toxic
effect of goldthioglucose is the lack of any consistent juxtaposition of the
sites of deposition of the stainable gold and the lipid. Gold was found only
within Kupffer cells and was distributed randomly throughout the hepatic
lobule. Lipid occurred in parenchymal cells and was concentrated centro-
lobularly. The data do not, however, definitely exclude an hepatotoxic
effect of the goldthioglucose as a cause of a portion of the hepatic fatty
change. If an idiosyncratic type of toxicity were operating, the effects on
the liverwould not necessarily be proportional to the dose ofgoldthioglucose.
With the exception of lobular distribution, the fatty change in the livers
of goldthioglucose-obese mice resembled that in insulin-polyphagic rats and
in rats made polyphagic and obese by hypothalamic electrocoagulation. In
all cases lipid was deposited in the cytoplasm of parenchymal cells as small,
discrete droplets. The droplets showed little tendency to coalesce, even in
very fatty cells, and fatty cysts as seen in choline deficiency"' were absent or
314
Volume 33, February 1961FIGs. 1-4. Representative livers of mice from Experiment II. In each of the figures.
the structure nearest the center of the plate is a portal area (P) and the structure
farthest from the center is a central vein (C). Lipid appears black. Frozen sections,
oil red 0, hematoxylin, and light green (x140).
FIG. 1. Single injection of goldthioglucose, obese. Abundant centrolobular lipid.
FIG. 2. Single injection, not obese. Small droplets of lipid near central vein.
FIG. 3. Multiple injections. Small droplets of lipid near central vein.
FIG. 4. No injections. Virtually tno stainiable lipid.
ioL
002
4'rFIG. 5. Liver of obese mouse. Abundant lipid present as small droplets in parenchymal
cells. Frozen section, oil red 0, hematoxylin, and light green (x1200).
FIG. 6. Liver of obese mouse. Intranuclear lipid in parenchymal cell. Frozen section,
oil red 0, hematoxylin, and light green (x1200).
FIG. 7. Liver of mouse after multiple injections of goldthioglucose. Pigment in
Kupffer cells stained black. Central vein (C) in lower right, portal area (P) in upper
left. Phase contrast, SnCl2 reaction (x140).
FIG. 8. Liver of mouse after multiple injectionis. Pigment in Kupffer cells. Oil red 0,
hematoxylin, and light green (x1200).4 '
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FIG. 9. Electron micrograph of parenchymal cell of liver of obese mouse of Experi-
ment II. Narrow cytoplasmic septa separate adjacent vacuoles in which only small
amounts of lipid remain after fixation and embedding. Mitochondria and ergastoplasm
are normal (xlO,OOO).
FIG. 10. Electron micrograph of Kupffer cell of mouse that received multiple
injections of goldthioglucose. Gold-containing pigment has crystalloid pattern
(xlO,000).
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t IFIG. 11. Electron micrograph of parenchymal cell of liver of mouse that received
niultiple in;jections of goldthioglucose. A small lipid-containinig vacuole is present
(bottom). Mitochondria and ergastoplasm are normal (xlO,OOO).
FIG. 12. Electron micrograph of parenchymal cell of liver of uninljected mouse. Mito-
chondria and ergastoplasm are similar to those in the preceding figures (xlO,OOO).Hepatic lipid and goldthioglucose obesity I MEYER, IMAI, SCOTT
rare. Fibrosis, necrosis, and disturbance of the lobular architectural pattern
were absent. Intranuclear droplets of stainable lipid occurred in scattered
cells in each condition.
The single feature that distinguished the fatty accumulation in livers of
goldthioglucose-obese mice from that in insulin-treated' or hypothalamic-
obese rats' was the lobular distribution of the excess lipid. In the rats, the
fatty change was always preponderant in the periportal areas. An explana-
tion for the difference is not apparent. One hypothesis that might be con-
sidered is that the hepatic lobules of rats and mice have different localizations
of certain enzymatic or circulatory factors. A second possibility is that the
difference in distribution of fat is a result of dietary factors. In choline-
deficient mice, the type of dietary fat has been reported to influence the
lobular localization of hepatic lipid.' The hypothalamic and insulin-treated
rats received more saturated fat than the goldthioglucose-injected mice, but
both received approximately the same dietary concentration of unsaturated
fat. Neither diet was deficient in any known essential nutrient. With the
exception that the rats received approximately 10 per cent more fat than the
mice, distribution of calories among protein, fat, and carbohydrate, and the
content of salts and fiber were similar. A third possibility is that the gold-
thioglucose, through a toxic effect, influenced the lobular site of deposition
of lipid accumulating under the influence of polyphagia and obesity.
Choline deficiency under certain circumstances produces centrolobular
fatty change in the livers of mice,""' but we do not believe that the fat
accumulation in the livers of goldthioglucose-obese mice is related to choline.
No evidence ofcholine deficiency was present in controls, and the contents of
protein, methionine, and choline were much higher than in diets used to
produce choline deficiency. Hyperalimentation in rats did not raise the per
cent dietary requirement of choline."
Lesions in the ventromedial hypothalamic nuclei have been demonstrated
consistently in goldthioglucose-obese mice. The lesions consist of edema,
hemorrhage, and necrosis with loss of neurons and subsequent gliosis.6'
Since destruction of the ventromedial hypothalamic nuclei of mice' and of
rats8 by stereotaxic electrocoagulation also produces polyphagia and obesity,
it seems wellestablished that the effect of goldthioglucose on food intake and
body weight is a result of total or partial destruction of appetite-inhibiting
centers in the hypothalamus. Physiologically and biochemically, goldthio-
glucose-obese mice closely resemble hypothalamic-obese rats5""' in that
their obesity is "regulatory" (increased caloric intake)""'""' rather than
"metabolic" (increased basal rate of lipogenesis) as in certain other forms
of obesity.1"'l'
" " 2178 n It is evident that at the present the difference in
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hepatic reaction to polyphagia and obesity in goldthioglucose-obese mice and
hypothalamic-obese rats cannot be attributed to differences in the metabol-
ism of the two forms of obesity.
The dissimilarity in lobular position of lipid in livers of hypothalamic-
obese rats and goldthioglucose-mice may be a result of a species difference
in lobular localization of function, but the other possible explanations that
have been discussed cannot be discarded at the present time. The evidence in
favor of a species difference appears strong enough to necessitate more
extensive investigation before observations of hepatic effects of obesity in
one species can be generalized to other species.
SUMMARY
Obesity following injection of goldthioglucose in mice is associated with
centrolobular deposition of lipid in their livers and hepatomegaly. The lipid
is deposited in parenchymal cells chiefly as small cytoplasmic droplets that
bear no consistent relationship to mitochondria, ergastoplasm, or other
organelles. Occasional nuclei also contain lipid. Neither the deposition of
fat in the livers nor the hepatomegaly can be accounted for entirely on the
basis of a direct (toxic) action of goldthioglucose; therefore, they appear
attributable at least in part to the effects of polyphagia and obesity.
Hypothalamic polyphagia and obesity in rats are known to result in
accumulation of hepatic fat in periportal location. The dissimilarity in the
lobular site of lipid in the livers of goldthioglucose-obese mice and hypo-
thalamic-obese rats may represent a species difference, or it may be a result
of differences in the experimental treatment of the rats and the mice.
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